Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01427270
Other study ID # ONU3704
Secondary ID 2011-005060-26
Status Completed
Phase Phase 3
First received August 30, 2011
Last updated November 6, 2014
Start date August 2011
Est. completion date October 2014

Study information

Verified date November 2014
Source Purdue Pharma LP
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationPoland: Office for Registration of Medicinal Products, Medical Devices and Biocidal ProductsCzech Republic: State Institute for Drug ControlItaly: The Italian Medicines Agency
Study type Interventional

Clinical Trial Summary

The primary objective is to assess the efficacy of oxycodone/naloxone (OXN) for the management of opioid-induced constipation (OIC) compared to oxycodone controlled-release tablets (OXY) in subjects with moderate to severe low back pain and OIC who require around-the-clock opioid therapy.


Recruitment information / eligibility

Status Completed
Enrollment 455
Est. completion date October 2014
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria include:

- Male and female subjects = 18 years of age with moderate to severe, chronic low back pain (lasting at least several hours daily) as their predominant pain condition for at least 3 months prior to screening period;

- The low back pain must be related to nonmalignant and nonneuropathic conditions and may be with or without radiation;

- Subjects must have a self-reported history of opioid induced constipation (OIC).

Exclusion Criteria include:

- Subjects with rheumatoid arthritis or other inflammatory arthritis;

- Subjects with neuropathic conditions that have been painful or required therapy within the past 3 months;

- Subjects with evidence of significant structural abnormalities of the gastrointestinal (GI) tract or other significant conditions affecting GI motility;

- Subjects with chronic constipation not related to opioid use;

- Subjects who had surgical procedures directed towards the source of chronic low back pain within 6 months of the screening visit or planned during the study;

- Subjects with a history of malignancy within the past 2 years, with the exception of basal cell carcinoma that has been successfully treated.

Other protocol specific inclusion/exclusion criteria may apply.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Oxycodone/Naloxone controlled-release
Oxycodone/Naloxone controlled-release tablets (10/5 - 40/20 mg) taken orally every 12 hours
Oxycodone HCl controlled-release
Oxycodone HCl controlled-release tablets (10 - 40 mg) taken orally every 12 hours
Placebo
Placebo tablets to match OXN or OXY taken orally every 12 hours

Locations

Country Name City State
Czech Republic Investigational Site Brno
Czech Republic Investigational Site Hradec Kralove
Czech Republic Investigational Site Most
Czech Republic Investigational Site Olomouc
Czech Republic Investigational Site Praha 10
Czech Republic Investigational Site Praha 4 - Krc
Czech Republic Investigational Site Praha 6
Czech Republic Investigational Site Rychnov nad Kneznou
Czech Republic Investigational Site Sternberk
Czech Republic Investigational Site Vysoke Myto
Czech Republic Investigational Site Zlin
Czech Republic Investigational Site Znojmo
Italy Investigational Site Catania
Poland Investigational Site Bielsko-Biala
Poland Investigational Site Bydgoszcz
Poland Investigational Site Bydgoszcz
Poland Investigational Site Gdansk
Poland Investigational Site Gdansk
Poland Investigational Site Gdynia
Poland Investigational Site Katowice
Poland Investigational Site Katowice
Poland Investigational Site Lublin
Poland Investigational Site Lublin
Poland Investigational Site Torun
United States Investigational Site Alabaster Alabama
United States Investigational Site Albuquerque New Mexico
United States Investigational Site Altoona Pennsylvania
United States Investigational Site Anaheim California
United States Investigational Site Anaheim California
United States Investigational Site Anaheim California
United States Investigational Site Arlington Texas
United States Investigational Site Athens Texas
United States Investigational Site Austell Georgia
United States Investigational Site Austin Texas
United States Investigational Site Aventura Florida
United States Investigational Site Baton Rouge Louisiana
United States Investigational Site Bay City Michigan
United States Investigational Site Beavercreek Ohio
United States Investigational Site Birmingham Alabama
United States Investigational Site Bloomington Illinois
United States Investigational Site Blue Ridge Georgia
United States Investigational Site Boise Idaho
United States Investigational Site Boynton Beach Florida
United States Investigational Site Bradenton Florida
United States Investigational Site Canton Georgia
United States Investigational Site Cedarhurst New York
United States Investigational Site Chicago Illinois
United States Investigational Site Chino California
United States Investigational Site Cincinnati Ohio
United States Investigational Site Clearwater Florida
United States Investigational Site Clermont Florida
United States Investigational Site Cleveland Ohio
United States Investigational Site Clinton Utah
United States Investigational Site Columbus Ohio
United States Investigational Site Columbus Ohio
United States Investigational Site Columbus Georgia
United States Investigational Site Coral Gables Florida
United States Investigational Site Covington Louisiana
United States Investigational Site Dallas Texas
United States Investigational Site Dallas Texas
United States Investigational Site Daytona Beach Florida
United States Investigational Site Elkin North Carolina
United States Investigational Site Evansville Indiana
United States Investigational Site Fall River Massachusetts
United States Investigational Site Franklin Ohio
United States Investigational Site Franklin Tennessee
United States Investigational Site Fresno California
United States Investigational Site Fresno California
United States Investigational Site Ft. Lauderdale Florida
United States Investigational Site Glendale California
United States Investigational Site Golden Colorado
United States Investigational Site Goodyear Arizona
United States Investigational Site Goodyear Arizona
United States Investigational Site Great Neck New York
United States Investigational Site Groveport Ohio
United States Investigational Site Gulf Shores Alabama
United States Investigational Site Hazelwood Missouri
United States Investigational Site Hialeah Florida
United States Investigational Site Hialeah Florida
United States Investigational Site Hollywood Maryland
United States Investigational Site Homewood Alabama
United States Investigational Site Hot Springs Arkansas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Houston Texas
United States Investigational Site Humble Texas
United States Investigational Site Huntsville Alabama
United States Investigational Site Inverness Florida
United States Investigational Site Jacksonville Florida
United States Investigational Site Jacksonville Florida
United States Investigational Site Jenkintown Pennsylvania
United States Investigational Site Johns Creek Georgia
United States Investigational Site Johnstown Pennsylvania
United States Investigational Site Jupiter Florida
United States Investigational Site Kansas City Kansas
United States Investigational Site La Mesa California
United States Investigational Site Laguna Hills California
United States Investigational Site Las Vegas Nevada
United States Investigational Site Lexington Kentucky
United States Investigational Site Little Rock Arkansas
United States Investigational Site Long Beach California
United States Investigational Site Los Angeles California
United States Investigational Site Los Angeles California
United States Investigational Site Los Angeles California
United States Investigational Site Los Gatos California
United States Investigational Site Madisonville Kentucky
United States Investigational Site Marietta Georgia
United States Investigational Site Marrero Louisiana
United States Investigational Site Meridian Idaho
United States Investigational Site Metairie Louisiana
United States Investigational Site Miami Florida
United States Investigational Site Miami Florida
United States Investigational Site Miami Florida
United States Investigational Site Miami Florida
United States Investigational Site Miami Florida
United States Investigational Site Miami Lakes Florida
United States Investigational Site Mobile Alabama
United States Investigational Site Myrtle Beach South Carolina
United States Investigational Site Naples Florida
United States Investigational Site Naples Florida
United States Investigational Site National City California
United States Investigational Site New Haven Connecticut
United States Investigational Site New Port Richey Florida
United States Investigational Site New Tazewell Tennessee
United States Investigational Site New Windsor New York
United States Investigational Site New York New York
United States Investigational Site North Attleboro Massachusetts
United States Investigational Site North Hollywood California
United States Investigational Site North Massapequa New York
United States Investigational Site North Miami Beach Florida
United States Investigational Site North Richland Hills Texas
United States Investigational Site Oceanside California
United States Investigational Site Oklahoma City Oklahoma
United States Investigational Site Orlando Florida
United States Investigational Site Oviedo Florida
United States Investigational Site Paramount California
United States Investigational Site Perry Georgia
United States Investigational Site Philadelphia Pennsylvania
United States Investigational Site Phoenix Arizona
United States Investigational Site Phoenix Arizona
United States Investigational Site Phoenixville Pennsylvania
United States Investigational Site Pinconning Michigan
United States Investigational Site Pinellas Park Florida
United States Investigational Site Pinellas Park Florida
United States Investigational Site Plano Texas
United States Investigational Site Plantation Florida
United States Investigational Site Port Orange Florida
United States Investigational Site Richmond California
United States Investigational Site Richmond Virginia
United States Investigational Site Richmond Virginia
United States Investigational Site Rochester Michigan
United States Investigational Site Roseville California
United States Investigational Site Sacramento California
United States Investigational Site Sacramento California
United States Investigational Site Salt Lake City Utah
United States Investigational Site Salt Lake City Utah
United States Investigational Site San Antonio Texas
United States Investigational Site San Antonio Texas
United States Investigational Site San Diego California
United States Investigational Site Sanford Florida
United States Investigational Site Santa Ana California
United States Investigational Site Santa Clarita California
United States Investigational Site Savannah Georgia
United States Investigational Site South Miami Florida
United States Investigational Site Spartanburg South Carolina
United States Investigational Site St. Louis Missouri
United States Investigational Site St. Louis Missouri
United States Investigational Site Stratford New Jersey
United States Investigational Site Sugar Land Texas
United States Investigational Site Tamarac Florida
United States Investigational Site Tampa Florida
United States Investigational Site Tampa Florida
United States Investigational Site Tempe Arizona
United States Investigational Site Tipton Pennsylvania
United States Investigational Site Toledo Ohio
United States Investigational Site Tomball Texas
United States Investigational Site Toms River New Jersey
United States Investigational Site Troy Michigan
United States Investigational Site Tucson Arizona
United States Investigational Site Valley Village California
United States Investigational Site Virginia Beach Virginia
United States Investigational Site Voorhees New Jersey
United States Investigational Site Warwick Rhode Island
United States Investigational Site Waterbury Connecticut
United States Investigational Site Wellington Florida
United States Investigational Site West Jordan Utah
United States Investigational Site Wichita Kansas
United States Investigational Site Williamsville New York
United States Investigational Site Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Purdue Pharma LP

Countries where clinical trial is conducted

United States,  Czech Republic,  Italy,  Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall complete spontaneous bowel movement (CSBM) responder rates The overall Complete Spontaneous Bowel Movement (CSBM) responder rates over the 12 week double-blind period comparing OXN to OXY Weeks 1 through 12 No
Secondary CSBM Responder at least 50% of the weeks in the double-blind period Weeks 1 through 12 No
Secondary Laxative-free Responder at least 50% of the weeks in the double-blind period Weeks 1 through 12 No
See also
  Status Clinical Trial Phase
Completed NCT03916705 - Thoraco-Lumbar Fascia Mobility N/A
Completed NCT04007302 - Modification of the Activity of the Prefrontal Cortex by Virtual Distraction in the Lumbago N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Recruiting NCT03600207 - The Effect of Diaphragm Muscle Training on Chronic Low Back Pain N/A
Completed NCT04284982 - Periodized Resistance Training for Persistent Non-specific Low Back Pain N/A
Recruiting NCT05600543 - Evaluation of the Effect of Lumbar Belt on Spinal Mobility in Subjects With and Without Low Back Pain N/A
Withdrawn NCT05410366 - Safe Harbors in Emergency Medicine, Specific Aim 3
Completed NCT03673436 - Effect of Lumbar Spinal Fusion Predicted by Physiotherapists
Completed NCT02546466 - Effects of Functional Taping on Static Postural Control in Patients With Non-specific Chronic Low Back Pain N/A
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05156242 - Corticospinal and Motor Behavior Responses After Physical Therapy Intervention in Patients With Chronic Low Back Pain. N/A
Recruiting NCT04673773 - MY RELIEF- Evidence Based Information to Support People Aged 55+ Years Living and Working With Persistent Low-back Pain. N/A
Completed NCT06049277 - Mulligan Technique Versus McKenzie Extension Exercise Chronic Unilateral Radicular Low Back Pain N/A
Completed NCT06049251 - ELDOA Technique Versus Lumbar SNAGS With Motor Control Exercises N/A
Completed NCT04980469 - A Study to Explore the Effect of Vitex Negundo and Zingiber Officinale on Non-specific Chronic Low Back Pain Due to Sedentary Lifestyle N/A
Completed NCT04055545 - High Intensity Interval Training VS Moderate Intensity Continuous Training in Chronic Low Back Pain Subjects N/A
Recruiting NCT05944354 - Wearable Spine Health System for Military Readiness
Recruiting NCT05552248 - Assessment of the Safety and Performance of a Lumbar Belt
Completed NCT05801588 - Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life N/A
Completed NCT05811143 - Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.